VBI Vaccines Inc expected to post a loss of $1.25 a share - Earnings Preview

VBI Vaccines

05/05/2023 19:35

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 8
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 548.4% increase in revenue to $817 thousand from $126
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for VBI Vaccines Inc is
for a
loss of $1.25 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $4​, above​ its last closing price of $2.68. ​​​

This summary was machine generated May 5 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated